Skip to main content
Clinical Trials/NCT01048021
NCT01048021
Completed
N/A

Pulmonary Function Changes and Diaphragmatic Paralysis Following Ultrasound Guided Supraclavicular Brachial Plexus Blockade: The Effects of Decreased Local Anesthetic Volume

University of Manitoba1 site in 1 country30 target enrollmentOctober 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diaphragmatic Function
Sponsor
University of Manitoba
Enrollment
30
Locations
1
Primary Endpoint
Forced expiratory volume in one second (FEV1)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This clinical trial is being conducted to study lung function and movement of the major muscle involved in breathing (the diaphragm) after a brachial plexus nerve block (nerve "freezing"). The purpose of this study is to find out what effects (good and bad) ultrasound guided nerve freezing has on the movement of the patient's diaphragm and their lung function.

The potential advantage of ultrasound guidance will be a lesser chance of freezing the nerves that innervate the diaphragm and thus having less of an effect on lung function.

Detailed Description

The supraclavicular approach to brachial plexus blockade was first described by Kulenkampf in 1911. With classic "blind" techniques, an incidence of pneumothorax has been reported ranging from 0.5-6.0%, limiting its widespread use, despite the belief that the supraclavicular approach is the most consistent, effective technique for anesthetizing the brachial plexus. With the advent of ultrasound guidance and real time visualization this risk has been minimized and a resurgence in utilization of this approach has occurred. Increased block success, diminished performance times, and lower anesthetic volumes have been observed with this technique when compared to nerve stimulator techniques. Despite these advantages, brachial plexus anesthesia above the clavicle is associated with diaphragmatic dysfunction and caution must be demonstrated in patients with respiratory disease. Interscalene brachial plexus blockade has been widely documented to produce a 100% incidence of hemidiaphragmatic paresis and an associated 25% mean reduction in forced vital capacity (FVC) with local anesthetic volumes ranging from 20 - 45mL 8-10, these parameters for supraclavicular brachial plexus blockage are not as well defined. Previous investigations report an incidence of hemidiaphragmatic paresis of 1-75% with supraclavicular brachial plexus blockade. This study will address whether diaphragmatic function and respiratory mechanics can be preserved with lower anesthetic volumes in ultrasound guided supraclavicular brachial plexus blockade.

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
April 2010
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Patricia Myktiuk

Dr. Patricia Mykytiuk

University of Manitoba

Eligibility Criteria

Inclusion Criteria

  • eligible patients undergoing Supraclavicular blockade

Exclusion Criteria

  • \< 18 years of age,
  • mental illness precluding informed consent,
  • infection at the injection site,
  • coagulopathy,
  • allergy to local anesthetics,
  • inability to comprehend English,
  • pulmonary disease, and
  • pregnancy

Outcomes

Primary Outcomes

Forced expiratory volume in one second (FEV1)

Time Frame: 60 minutes

Forced vital capacity (FVC)

Time Frame: 60 minutes

Peak expiratory flow (PEF)

Time Frame: 60 minutes

Study Sites (1)

Loading locations...

Similar Trials